Lurasidone Inactive Metabolite 14283(186204-32-0)
- Name: Lurasidone Inactive Metabolite 14283
- Synonyms:Lurasidone Inactive Metabolite 14283
- Molecular Formula:C28H37ClN4O3S
- Molecular Weight:0
- CAS Registry Number:186204-32-0
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.186204-32-0 (1S,2S,6R,7S,8R)-4-{[(1R,2R)-2-{[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl}cyclohexyl]methyl}-8-hydroxy-4-azatricyclo[5.2.1.02, ]decane-3,5-dione hydrochloride
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)]
CAS No.186204-32-0 Lurasidone Inactive Metabolite 14283
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:Lurasidone Inactive Metabolite 14283
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)]
CAS No.186204-32-0 Lurasidone Inactive Metabolite 14283
Assay:97% Appearance:Powder or liquid Package:According to customer Storage:Store in a tightly closed container, in a cool and dry place. Transportation:Fedex,DHL,TNT,BY SEA and BY AIR Application:Medicinal Chemistry Biomedicine Pharmaceutical intermediates Chemistry experiment Biological experiments Chemical reagent For R&D use only.
Min. Order:10Milligram
Supplier:Amadis Chemical Co., Ltd. [
China (Mainland)]
CAS No.186204-32-0 Lurasidone Metabolite 14283 hydrochloride CAS No.186204-32-0
Assay:99.90% Appearance:solid or liquid Package:As customer's requested Storage:sealed in cool and dry place Transportation:by courier/air/sea Application:Pharma Intermediate
Min. Order:0
Supplier:Guangdong Juda Chemical Industrial Co.,Limited [
China (Mainland)]

Other Product
- 1018614-41-9/2-methyl-1,4-oxazepane(SALTDATA: FREE)
- 1261958-40-0/6-(3-Benzyloxyphenyl)picolinic acid
- 88111-83-5/1H-Cyclopentcisoxazole-4,5,6-triol, hexahydro-1-methyl-3-(phenylthio)-, triacetate (ester), 3R-(3.alpha.,3a.beta.,4.beta.,5.alpha.,6.beta.,6a.beta.)-
- 108127-91-9/4-AMino-1,2-dihydroisoquinolin-1-one hydrochloride
- 1404299-76-8/3-broMo-7H-IMidazo[1,2-c]pyrrolo[3,2-e]pyriMidine
- 1181458-02-5/2-ISOBUTOXY-1-ETHANAMINE HYDROCHLORIDE
- 40872-10-4/(2R,5S)-2,5-Diaminoadipic acid
- 147687-18-1/Ro76477
- 442552-57-0/SALOR-INT L247367-1EA
- 1398338-67-4/methyl 4-chloro-5-iodo-2-(2-(phenylsulfonyl)acetamido)benzoate
- 402475-33-6/DIMETHYL-W84 DIBROMIDE
- 923145-19-1/1-(4-METHOXYPYRIMIDIN-2-YL)PIPERIDINE-4-CARBOXYLIC ACID
- 1079264-82-6/2-chloro-N-(5-(diMethylaMino)-2-nitrophenyl)-5-nitrobenzaMide
- 27361-84-8/2-(chloroMethyl)-1-propyl-Pyrrolidine
- 921602-83-7/2,2-DIFLUOROCYCLOHEXANAMINE HYDROCHLORIDE
- 1386986-05-5/2,5-dichloro-3-(methoxymethyl)pyridine
- 1368386-88-2/2-(2-Hydroxyphenyl)-[1,2,4]triazolo[1,5-a]pyridine-8-carboxylic acid
- 56800-08-9/(E)-1,3-Dichloro-1-butene
- 198630-68-1/D-Alanine, N-(2-methylpropyl)-, methyl ester (9CI)
- 186204-32-0/Lurasidone Inactive Metabolite 14283
- 8003-24-5/4-methoxy-3-tert-butyl-phenol
- 19729-27-2/3-[(Methoxycarbonylmethyl)thio]-N-(1-oxodecyl)-L-Ala-Gly-L-Val-OMe
- 343330-37-0/Ethanone, 1-[3-(1,1-dimethylethyl)-2,3-dihydro-2-furanyl]- (9CI)
- 697287-41-5/(S)-N-[1-(4-Cyclopropylmethyl-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl)-ethyl]-3-(2-fluoro-phenyl)acrylamide
- 1312535-18-4/3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline
- 205810-25-9/pyrene-1,6-diyldiboronic acid
- 1158750-51-6/1,7-Diazaspiro[4.5]decane, 1-Methyl-
- 1464091-69-7/6-broMo-3-ethyl-iMidazo[1,2-a]pyrazine
- 154644-14-1/PANTOPRAZOLE SODIUM SESQUIHYDRATE
- 697242-36-7/3-(1H-IMIDAZOL-1-YL)-6-METHOXYPYRIDAZINE